EVARREST(R) Fibrin Sealant Patch gains FDA approval on expanded indication
Ethicon announced the FDA has approved an expanded indication for EVARREST® Fibrin Sealant Patch, which leverages biologics to rapidly stop problematic bleeding during surgery. The expanded indication supports use of EVARREST® as an adjunctive hemostat across a range of surgical situations. October 25, 2016